<?xml version="1.0" encoding="ASCII"?>
<biogps><data><item key="owner">ArrayExpress Uploader</item><item key="ownerprofile_id">arrayexpress_sid</item><item key="species">mouse</item><item key="factors"><item><item key="GSM786802"><item key="STRAIN">B6</item></item></item><item><item key="GSM786802"><item key="STRAIN">B6</item></item></item><item><item key="GSM786802"><item key="STRAIN">B6</item></item></item><item><item key="GSM786802"><item key="STRAIN">B6</item></item></item><item><item key="GSM786802"><item key="STRAIN">B6</item></item></item><item><item key="GSM786807"><item key="STRAIN">B6.Sle1c2</item></item></item><item><item key="GSM786807"><item key="STRAIN">B6.Sle1c2</item></item></item><item><item key="GSM786807"><item key="STRAIN">B6.Sle1c2</item></item></item><item><item key="GSM786807"><item key="STRAIN">B6.Sle1c2</item></item></item><item><item key="GSM786807"><item key="STRAIN">B6.Sle1c2</item></item></item></item><item key="id">6600</item><item key="pop_total">0</item><item key="platform">6</item><item key="summary_wrapped">Sle1c is a sublocus of the NZM2410-derived Sle1 major susceptibility locus.  We have previously shown that Sle1c contributes to lupus...</item><item key="geo_gse_id">E-GEOD-31702</item><item key="owner_profile">/profile/8773/arrayexpressuploader</item><item key="factor_count">1</item><item key="sample_count">10</item><item key="tags"><item>cell</item><item>disease</item><item>lupus</item></item><item key="lastmodified">Dec.12, 2014</item><item key="is_default">False</item><item key="geo_id_plat">E-GEOD-31702_A-AFFY-45</item><item key="slug">cd4-t-cell-gene-expression-in-b6-vs-b6sle1c2-mice</item><item key="geo_gds_id"/><item key="name">CD4+ T cell gene expression in B6 vs B6.Sle1c2 mice</item><item key="created">Nov.11, 2014</item><item key="summary">Sle1c is a sublocus of the NZM2410-derived Sle1 major susceptibility locus.  We have previously shown that Sle1c contributes to lupus pathogenesis by conferring CD4+ T cell-intrinsic hyperactivation and increased susceptibility to chronic graft-versus-host disease (cGVHD) that mapped to the centromeric portion of the locus.  In this study, we have refined the centromeric sublocus to a 675Kb interval, termed Sle1c2.  Recombinant congenic strains expressing Sle1c2 exhibited a T cell-intrinsic CD4+ T cell hyperactivation and cGVHD susceptibility, similar to mice with the parental Sle1c. We performed a microarray analysis on CD4+ T cells to gain insights into the transcriptional programs that regulate the hyperactivation conferred by Sle1c2. CD4+ T cell cDNA was prepared from spenocytes from 5 mice from each strain and B6.Sle1c2 gene expression was compared to B6 gene expresion.</item><item key="source">http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-31702</item><item key="sample_source">http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-31702/samples/</item></data></biogps>
